Dyschromatosis universalis hereditaria
| Dyschromatosis universalis hereditaria | |
|---|---|
| Synonyms | DUH |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hyperpigmentation and hypopigmentation of the skin |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical diagnosis, genetic testing |
| Differential diagnosis | Dyschromatosis symmetrica hereditaria, vitiligo, xeroderma pigmentosum |
| Prevention | N/A |
| Treatment | No specific treatment |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
A rare genetic skin disorder
Dyschromatosis universalis hereditaria (DUH) is a rare genetic disorder characterized by a mixture of hyperpigmented and hypopigmented macules distributed over the body. It is an autosomal dominant condition, although autosomal recessive forms have also been reported.
Presentation[edit]
Individuals with dyschromatosis universalis hereditaria typically present with a mottled appearance of the skin due to the presence of both hyperpigmented and hypopigmented macules. These macules are usually distributed symmetrically across the body, including the trunk, limbs, and sometimes the face. The condition often becomes apparent in infancy or early childhood and tends to progress with age.
Genetics[edit]
DUH is primarily inherited in an autosomal dominant manner, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. However, some cases have been linked to autosomal recessive inheritance. Mutations in the ABCB6 gene have been associated with the condition, although the exact pathophysiological mechanisms remain unclear.
Pathophysiology[edit]
The pathophysiology of dyschromatosis universalis hereditaria involves abnormalities in the melanin production or distribution within the skin. The presence of both hyperpigmented and hypopigmented areas suggests a defect in the regulation of melanocyte function or melanin synthesis. The specific molecular pathways disrupted in DUH are still under investigation.
Diagnosis[edit]
The diagnosis of DUH is primarily clinical, based on the characteristic appearance of the skin. A detailed family history can aid in identifying the hereditary nature of the condition. Genetic testing may be used to confirm the diagnosis and identify mutations in the ABCB6 gene or other associated genes.
Management[edit]
There is currently no cure for dyschromatosis universalis hereditaria. Management focuses on cosmetic concerns and may include the use of cosmetic camouflage to even out skin tone. Patients should be monitored for any potential complications, although the condition is generally benign and does not affect overall health.
Prognosis[edit]
The prognosis for individuals with DUH is generally good, as the condition is primarily cosmetic and does not typically lead to other health issues. However, the psychological impact of the skin changes can be significant, and supportive care may be beneficial.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian